Extrapyramidal symptoms during SSRI therapy;Extrapyramidové příznaky při terapii SSRI

Ceska a Slovenska Psychiatrie

Volumn 98, Issue 1, 2002, Pages 33-40

  Goetz, M ^a   Hrdlicka M ^a   Papezova S ^a   Marsalek M ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Citalopram; Extrapyramidal syndrome; Fluoxetine; Fluvoxamine; Paroxetine; Sertraline; SSRI

Indexed keywords

CITALOPRAM; FLUVOXAMINE; NEUROLEPTIC AGENT; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

AKATHISIA; CASE REPORT; DEPRESSION; DRUG EFFECT; DYSKINESIA; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; HUMAN; INCIDENCE; MUSCLE RIGIDITY; PARKINSONISM; PUBLICATION; REVIEW; TARDIVE DYSKINESIA; TREMOR;

EID: 0036154131     PISSN: 12120383     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. O neurologických komplikacích léčby imipraminem
2. Paroxetine induces dystonia and parkinsonism in obsessive-compulsive disorder
3. Complex movement disorders induced by fluoxetine
4. Fluoxetine and extrapyramidal side effects
5. Fluoxetine end extrapyramidal side effects
6. Persistent dyskinesia in a patient receiving fluoxetine
7. Does fluoxetine exacerbate Parkinson's disease?
8. Fluoxetine and extrapyramidal side effects
9. Serotonergic modulation of strial dopamine measured with positron emission tomography (PET) and in vivo microdialysis
10. SSRI - Associated nocturnal bruxism in four patients
11. Fluoxetine and extrapyramidal side effects
12. Dystonias and dyskinesias of the jaw asociated with the use of the SSRIs
13. Changes in rat forebrain regions after cessation of long term fluoxetine treatment, relationship with brain concentrations of fluoxetine and norfluoxetine
14. Selective serotonin reuptake inhibitor-induced movement disorders
15. Extrapyramidal symptoms associated with cyclic antidepressant treatment: A review of the literature and consolidating hypotheses
16. Extrapyramidal side effects in elderly patients exposed to selective serotonin reuptake inhibitors
17. Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3-H-(3-hydroxyphenyl)-N-(1-propyl)-piperadine
18. Akathisia suicidality and fluoxetine
19. SSRI induzierte akathisie
20. Parkinsonism exacerbated by paroxetine
21. Effects of citalopram, a specific serotonin uptake inhibitor, in tardive dyskinesia and parkinsonism
22. SSRI-induced extrapyramidal side effects and akathisia: Implications for treatment
23. Movement disorders associated with the serotonin selective reuptake inhibitors
24. SSRIs and movement disorders: Is serotonin the culprit?
25. Fluoxetine induced akathisia: Clinical and theoretical implications
26. Paroxetine-Molindone interaction
27. Sebevražedné tendence vyvolané kombinací neuroleptika s SSRI (kazuistika)
28. Zvyšuje podávání antidepresiv pohotovost k sebevraždě?
29. Treatment of depression in Parkinson's disease using sertraline
30. Treatment of hypokinetic rigid syndrom with fluvoxamine
31. Extrapyramidal side effects and increased serum prolactin following fluoxetine a new antidepressant
32. Diabetes mellitus and tardive dyskinesia
33. The safety and tolerability of citalopram
34. Extrapyramidal side effects associated with paroxetine
35. Fluoxetine and suicidal behaviour, some clinical and theoretical aspects of a controversy
36. Sertraline and extrapyramidal side effects
37. Relationship between the locomotor hyperactivity induced by A 10 lesions and the destruction of the frontocortical dopaminergic innervation in the rat
38. Emergence of intense suicidal preoccupation during fluoxetine treatment
39. Serotonin interactions in the nigrostriatal system
40. A comparison of (-)deoxybenzomorphans devoid of opiate activity with their dextrorotatory phenolic counterparts suggests a role for sigma type receptors for psychotomimetic opiates and antipsychotic drugs
41. Role of sigma recepors in brain mechanism of movement